Analysis: Cigna Corporation

US:CI

Why is Cigna Corporation stock rising?

  • Signature rebate-free pharmacy model adoption ramp: Cigna Healthcare fully insured book in 2027, broader market scaling in 2028.
  • 2027 pharmacy benefit new business wins are already stronger than the prior two selling seasons combined.
  • Cigna raised its full-year 2026 adjusted EPS outlook to at least $30.45.
  • AI-enabled care coordination expansion to reach 20% more customers with emerging complex health needs.
  • Pharmacy Forward AI program expected to cut time to specialty therapy in half.

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Cigna Corporation and 4,900+ companies.

Sign in
5-day free pass. No card required.